Atlas Trials

Relapse Leukemia

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapse Leukemia

RecordFirmDate
Phase I/II Study of Enhanced CD33 CAR T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (NCT04835519)Beijing Boren Hospital2021-04-08
Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia (NCT05164042)Shenzhen University General Hospital2021-02-05
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy (NCT04282811)Gruppo Italiano Malattie EMatologiche dell'Adulto2020-07-24
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML (NCT04139434)Newave Pharmaceutical Inc2020-07-06
Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation (NCT03964922)Central Hospital, Nancy, France2019-09-01
Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia (NCT03799224)Peking University People's Hospital2018-12-01
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) (NCT03091933)Ciusss de L'Est de l'Île de Montréal2017-02-06
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia (NCT03181815)Sun Yat-sen University2016-01-01
Outcome Following Truncation of Asparaginase (NCT03987542)Birgitte Klug Albertsen2008-07-01
Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation (NCT02028650)huishengai2005-02-01

Track Relapse Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.